Elsevier Inc.

SHERPA: Unknown

People

  1. Lesokhin
    Lesokhin
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Hassoun
    Hassoun
  5. Mailankody
    Mailankody
  6. Hsu
    Hsu
  7. Korde
    Korde
  8. Chung
    Chung
  9. Shah
    Shah
  10. Landgren
    Landgren

Groups

  1. Center for Hematologic Malignancies (290)
  2. Hematologic Malignancies Research (290)
  3. Department of Medicine (261)
  4. Hematologic Malignancies, Division of (226)
  5. GSK Faculty (195)
  6. Sloan Kettering Institute Faculty (136)
  7. Bone Marrow Transplant (130)
  8. Myeloma (110)
  9. Molecular Pharmacology and Chemistry Program Faculty (93)
  10. Sloan Kettering Institute Postdocs (90)
Search Within
  1. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (156)
  2. Journal Article (108)
  3. Review (11)
  4. Editorial (7)
  5. Book Section (4)
  6. Research Letter (2)
  7. Book Whole (1)
  8. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (290)
  2. Hematologic Malignancies Research (290)
  3. Department of Medicine (261)
  4. Hematologic Malignancies, Division of (226)
  5. GSK Faculty (195)
  6. Sloan Kettering Institute Faculty (136)

More Groups

People
  1. Alexander Lesokhin (78)
  2. Sergio Giralt (73)
  3. David Chung (60)
  4. Heather Landau (60)
  5. Hani Hassoun (58)
  6. Sham Mailankody (54)

More People

Years
  1. 2025 (2)
  2. 2024 (15)
  3. 2023 (24)
  4. 2022 (14)
  5. 2021 (13)
  6. 2020 (22)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (84)
  2. Biology of Blood and Marrow Transplantation (80)
  3. Blood Cells, Molecules, and Diseases (12)
  4. Journal of Thoracic Oncology (12)
  5. Best Practice and Research: Clinical Haematology (11)
  6. Cell Metabolism (11)

More Publications

Results (290)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Association of HLA-E ligand and NKG2 receptor variation with relapse and mortality after haploidentical related donor transplantation
    Journal Article

    Petersdorf, E. W.; McKallor, C.; Malkki, M.; Hsu, K.; He, M.; Spellman, S. R.; Gooley, T.; Stevenson, P.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Editorial overview: Protein networks in health and disease
    Editorial

    Komives, E. A.; Chiosis, G.
    Current Opinion in Structural Biology (2025)

    Fulltext@MSK | Save
  • MagnetisMM-30: A phase 1B, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM)
    Meeting Abstract

    Lesokhin, A.; Raza, M.; Acosta, J.; Mueller, P. Y.; O'Connell, A.; Yver, A.; Lou, C.; Finn, G.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with Talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K.; Papadimitriou, M.; Blaney, P.; McPherson, A.; Chu, T.; Diamond, B.; Ziccheddu, B.; Shekarkhand, T.; Poos, A.; Brown, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)
    Meeting Abstract

    Maclachlan, K.; Shekarkhand, T.; Farzana, T.; Costa, B.; Firestone, R.; Jurgens, E.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of teclistamab among MajesTEC-1 eligible and ineligible population in the real-world setting for the treatment of relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Rajeeve, S.; Hashmi, H.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of granulocyte colony-stimulating factor exposure on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma
    Meeting Abstract

    Wang, A.; Shekarkhand, T.; Derkach, A.; Nemirovsky, D.; Tan, C.; Hamadeh, I.; Firestone, R.; Jurgens, E.; Miller, K.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save